Prostate Clinical Trials

TRIALS CURRENTLY OPEN

USOR 19191

Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer.

Also See STAR Trials – USOR #18103, #19151, #16238, #20248